The Decomposition of Human Remains a Biochemical Perspective
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Forensic Medicine
YEREVAN STATE MEDICAL UNIVERSITY AFTER M. HERATSI DEPARTMENT OF Sh. Vardanyan K. Avagyan S. Hakobyan FORENSIC MEDICINE Handout for foreign students YEREVAN 2007 This handbook is adopted by the Methodical Council of Foreign Students of the University DEATH AND ITS CAUSES Thanatology deals with death in all its aspects. Death is of two types: (1) somatic, systemic or clinical, and (2) molecular or cellular. Somatic Death: It is the complete and irreversible stoppage of the circulation, respiration and brain functions, but there is no legal definition of death. THE MOMENT OF DEATH: Historically (medically and legally), the concept of death was that of "heart and respiration death", i.e. stoppage of spontaneous heart and breathing functions. Heart-lung bypass machines, mechanical respirators, and other devices, however have changed this medically in favor of a new concept "brain death", that is, irreversible loss of Cerebral function. Brain death is of three types: (1) Cortical or cerebral death with an intact brain stem. This produces a vegetative state in which respiration continues, but there is total loss of power of perception by the senses. This state of deep coma can be produced by cerebral hypoxia, toxic conditions or widespread brain injury. (2) Brain stem death, where the cerebrum may be intact, though cut off functionally by the stem lesion. The loss of the vital centers that control respiration, and of the ascending reticular activating system that sustains consciousness, cause the victim to be irreversibly comatose and incapable of spontaneous breathing. This can be produced by raised intracranial pressure, cerebral oedema, intracranial haemorrhage, etc.(3) Whole brain death (combination of 1 and 2). -
Classification of Cell Death
Cell Death and Differentiation (2005) 12, 1463–1467 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd News and Commentary Classification of cell death: recommendations of the Nomenclature Committee on Cell Death G Kroemer*,1, WS El-Deiry2, P Golstein3, ME Peter4, D Vaux5, with or without, caspase activation and that ‘autophagic cell P Vandenabeele6, B Zhivotovsky7, MV Blagosklonny8, death’ represents a type of cell death with (but not necessarily W Malorni9, RA Knight10, M Piacentini11, S Nagata12 and through) autophagic vacuolization. This article details the G Melino10,13 2005 recommendations of NCCD. Over time, molecular definitions are expected to emerge for those forms of cell 1 CNRS-UMR8125, Institut Gustave Roussy, 39 rue Camille-Desmoulins, death that remain descriptive. F-94805 Villejuif, France 2 University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA Preface 3 Centre d’Immunologie INSERM/CNRS/Universite de la Mediterranee de Marseille-Luminy, Case 906, Avenue de Luminy, 13288 Marseille Cedex 9, It is obvious that clear definitions of objects that are only France shadows in Plato’s cage are difficult to be achieved. Cell death 4 The Ben May Institute for Cancer Research, University of Chicago, 924 E 57th and the different subroutines leading to cell death do not Street, Chicago, IL 60637, USA 5 escape this rule. Even worse, the notion of death is strongly Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, influenced by religious and cultural beliefs, which may UK 6 Molecular Signalling and Cell Death Unit, Department for Molecular Biomedical subliminally influence the scientific view of cell death. -
Guidelines for Determining Death Based on Neurological Criteria
GUIDELINES FOR DETERMINING DEATH BASED ON NEUROLOGICAL CRITERIA New Jersey 2014 1 These guidelines have been drafted by the New Jersey Ad Hoc Committee on Declaration of Death by Neurologic Criteria, under the leadership of Dr. John Halperin, M.D. and William Reitsma, RN. We are grateful for the hard work and knowledgeable input of each of the following medical, legal and health care professionals. The authors gratefully acknowledge the work of the New York State Department of Health and the New York State Task Force on Life and the Law, and the guidelines for Brain Death Determination they promulgated in 2011. This document provides the foundation for these guidelines. John J. Halperin, M.D., FAAN, FACP Medical Director, Atlantic Neuroscience Institute Chair, Department of Neurosciences Overlook Medical Center Summit, NJ Alan Sori, M.D., FACS Director of Surgical Quality, Saint Joseph's Regional Medical Center Paterson, NJ Bruce J. Grossman, M.D. Director of Pediatric Transport Services Pediatric Intensivist K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center Neptune, NJ Gregory J. Rokosz, D.O., J.D., FACEP Sr. Vice President for Medical and Academic Affairs/CMO Saint Barnabas Medical Center Livingston, NJ Christina Strong, Esq. Law Office of Christina W. Strong Belle Mead, NJ 2 GUIDELINES FOR DETERMINING DEATH BASED ON NEUROLOGICAL CRITERIA BACKGROUND This document provides guidance for determining death by neurological criteria (commonly referred to as “brain death”), aims to increase knowledge amongst health care practitioners about the clinical evaluation of death determined by neurological criteria and reduce the potential for variation in brain death determination policies and practices amongst facilities and practitioners within the State of New Jersey. -
Programmed Cell Death and Lysis in Bacteria and the Benefits to Survival
Programmed Cell Death and Lysis in Bacteria and the Benefits for Survival. Mirjam Boonstra Rijksuniversiteit Groningen 2009 Teachers: Prof. Dr. O.P. Kuipers & Dr. A.T. Kovacs 1 Introduction Bacterial cell death is an interesting phenomenon because it plays a crucial role in many important processes. Bacterial cell death does not just occur in the late stationary phase when nutrient limitation can lead to starvation. Bacteria are capable of initiating autolysis during certain conditions, such as biofilm formation, competence, sporulation and stress response. One form of lysis is autolysis, bacterial suicide. Autolysis in bacteria constitutes programmed cell death (PCD) because death of the cell is the result of an internal mechanism that can be activated by internal or external signals. Another cause of death of a subpopulation of cells is allolysis; allolysis is the killing of sibling cells by bacteria. There are many different mechanisms that can cause lysis in bacteria. Which mechanisms are used depends on the species of bacteria and the circumstances. The possible benefits to killing sibling cells are obvious; killing other cells releases their nutrients into the environment. But what are the benefits to killing yourself? The answer to this lies in the complex nature of bacterial communities. Bacteria are for instance, capable of forming biofilms in which there exists a spatial and temporal difference in gene expression of genetically identical bacteria. The difference in gene expression patterns plays an important role in deciding which cells undergo autolysis. Bacteria also undergo complex developmental processes such as sporulation and competence in which autolysis and allolysis play a crucial role. -
Death & Decomposition Part II
Death & Decomposition Part II Review: Why is TSD/PMI so important? Review: What happens in the Fresh (1st) Stage of Decomposition? STAGE 2: Bloat ⦿ 0-10 days ⦿ Putrefaction: bacterially-induced destruction of soft tissue and gas formation › Skin blisters and marbling › Build-up of fluids from ruptured cells and intestines Putrefaction – the gross stuff ➢ Decomposition that occurs as a result of bacteria and other microorganisms ➢ Results in gradual dissolution of solid tissue into gases and liquids, and salts Putrefaction ➢ Characteristics: ○ Greenish discoloration ○ Darkening of the face ○ Bloating and formation of liquid or gas-filled blisters ○ Skin slippage Putrefaction ➢ Begins about 36 hours after death ➢ Further destruction is caused by maggots and insects ➢ Above 40 F, insects will feed until the body is skeletonized Influences of Putrefaction ➢ Heavy clothing and other coverings speed up the process by holding in body heat ➢ Injuries to the body surface promote putrefaction ○ provide portals of entry for bacteria Marbling Stage 3: Active Decay ➢ 10-20 days after death ➢ Body begins to collapse and black surfaces are exposed ➢ Bloated body collapses and leaves a flattened body ➢ Body fluids drain from body Active Decay Active Decay: Destruction of Tissue • Severe decomp can result in complete destruction of soft tissue Active Decay: Advanced Decomposition Stage 4: Dry Decay ➢ 20-365 days after death ➢ Remaining flesh on body is removed and body dries out ➢ Body is dry and continues to decay very slowly due to lack of moisture ➢ -
Life After Death and the Devastation of the Grave
In Michael Martin and Keith Augustine, eds., The Myth of an Afterlife: The Case Against Life After Death, Rowman & Littlefield 2015. Life After Death and the Devastation of the Grave Eric T. Olson 1. Life After Death One of the fundamental questions of human existence is whether there is life after death. If we had an oracle willing to answer just one philosophical question by saying “Yes” or “No,” this is the one that many of us would ask. Not being an oracle, I am unable to tell you whether there is an afterlife. But I can say something about whether there could be. Is it even possible? Or is the hope that we have life after death as vain as the hope that we might find the largest prime number? One way to think about whether there could be life after death is to ask what would have to be the case for us to have it. If it were possible, how might it be accomplished? Suppose you wanted to know whether it was possible for a hu- man being to visit another galaxy and return to earth. To answer this question, you would need to know what such a journey would involve. What sort of spaceship or other means of transport would it require? How fast would it have to go, and how long would the journey take? Only once you knew such things would you be able to work out whether it could possibly be done. In the same way, we need to know what our having life after death would require in order to see whether it is possible. -
Three End-Of-Life Cases: Resolving Their Moral Dilemmas
Vol. 33:2 Summer 2017 Three End-of-Life Cases: Resolving Their Moral Dilemmas RENÉ E MIRKES, OSF, PHD An organization of Roman Catholic physicians presented a set of questions to guide moral assessment of three end-of-life cases. The questions for each scenario highlight a corresponding ethical dilemma: (Case #1) the determination of brain death by neurological criteria; (Case #2) the decision to withhold or withdraw artificial nutrition and hydration from an unresponsive wakefulness syndrome (UWS) (formerly referred to as persistent vegetative state, [PVS]) patient; and (Case #3) the administration of pain medication that hastens death. To adjudicate the moral concern raised in each of these clinical cases, the following moral analyses appeal to the natural law perspective summarized in the Ethical & Religious Directives for Catholic Health Care Services1 and in other philosophical resources, both Catholic and secular. CASE #1 An 18-year-old involved in a motorcycle accident was brought to the emergency room with massive head trauma and life support. A brain angiogram showed no blood flow, and a neurological examination revealed no brainstem reflexes as well as persistent apnea. Blood pressure medication was required for heart rate and blood pressure control. Since the patient was an organ donor, the organ recovery team was called in after he was declared brain dead. Discussion (1) When and how do we declare a person dead? What is the difference between theological and scientific definitions of death? (A) A living human being is a substantial union of a (mammalian) body and a rational soul. We are not spiritual beings who use or have bodies. -
Guideline Completion of Death Certificates
Department of Health Center for Health Statistics Guideline Revised – 2/23/17 Title: Completion of Death Certificates Number: CHS D-10 References: RCW 70.58.170 Contact: Daniel O’Neill, Senior Policy Analyst Phone: 360-236-4311 Email: [email protected] Effective Date: February 23, 2017 Approved By: Christie Spice The Department of Health provides this guideline for medical certifiers of death certificates. Medical certifiers include allopathic and osteopathic physicians, physician assistants, advanced registered nurse practitioners, chiropractors, coroners and medical examiners to follow when completing death certificates. The Department receives complaints that health care providers fail to complete death certificates in a timely manner or fail to accurately list the cause of death on the death certificate. The death certificate provides important information about the decedent and the cause of death. Death certification errors are common and range from minor to severe. Under RCW 70.58.170, a funeral director or person having the right to control the disposition of human remains must present the death certificate to the medical certifier last in attendance upon the deceased. The medical certifier then has two business days to certify the cause of death according to his or her best knowledge and sign or electronically approve the certificate, unless there is good cause for not doing so. The medical certifier should register cause and manner of death information through the Washington State Electronic Death Reporting System (EDRS). The EDRS facilitates timely registration of the death and rapid collection of cause and manner of death information. The EDRS can be found at https://fortress.wa.gov/doh/edrs/EDRS/. -
Towards Accelerated Autolysis? Dynamics of Phenolics, Proteins, Amino Acids and Lipids in Response to Novel Treatments and During Ageing of Sparkling Wine
beverages Article Towards Accelerated Autolysis? Dynamics of Phenolics, Proteins, Amino Acids and Lipids in Response to Novel Treatments and during Ageing of Sparkling Wine Gail B. Gnoinski 1,*, Dugald C. Close 1, Simon A. Schmidt 2 and Fiona L. Kerslake 1 1 Horticulture Centre, Tasmanian Institute of Agriculture, University of Tasmania, Sandy Bay, Hobart 7005, Australia; [email protected] (D.C.C.); fi[email protected] (F.L.K.) 2 The Australian Wine Research Institute, Glen Osmond, Adelaide 5064, Australia; [email protected] * Correspondence: [email protected] Abstract: Premium sparkling wine produced by the traditional method (analogous to the French méthode champenoise) is characterised by the development of aged wine character as a result of a second fermentation in the bottle with lees contact and lengthy ageing. Treatments (microwave, ultrasound, or β-glucanase enzymes) were applied to disrupt the cell wall of Saccharomyces cerevisiae and added to the tirage liquor for the second fermentation of Chardonnay-Pinot Noir base wine cuvée and compared to a control, to assess effects on the release of phenolics, proteins, amino acids, and lipids at 6, 12 and 18 months post-tirage. General responses to wine ageing included a 60% Citation: Gnoinski, G.B.; Close, D.C.; increase in the total phenolic content of older sparkling wines relative to younger wines and an Schmidt, S.A.; Kerslake, F.L. Towards increase in protein concentration from 6 to 12 months bottle age. Microwave and β-glucanase enzyme Accelerated Autolysis? Dynamics of treatments of yeast during tirage preparation were associated with a 10% increase in total free amino Phenolics, Proteins, Amino Acids and acid concentration and a 10% increase in proline concentration at 18 months bottle age, compared to Lipids in Response to Novel control and ultrasound treatment. -
2018 Infant Mortality and Selected Birth Characteristics
OCTOBER 2020 Infant Mortality and Selected Birth Characteristics 2019 South Carolina Residence Data and Environmental Control Vital Statistics CR-012142 11/19 Executive Summary Infant mortality, defined as the death of a live-born baby before his or her first birthday, reflects the overall state of a population’s health. The infant mortality rate is the number of babies who died during the first year of life for every 1,000 live births. The South Carolina (SC) Department of Health and Environmental Control (DHEC) collects and monitors infant mortality data to improve the health of mothers and babies in our state. In 2019, there were 391 infants who died during the first year of life. While the most recent national data shows that the US infant mortality rate in 2018 (5.7 infant deaths per 1,000 live births)1 surpassed the Healthy People (HP) 2020 Goal of no more than 6.0 infant deaths per 1,000 live births2, the SC infant mortality rate is still higher than the HP target despite a decrease of 4.2% from 7.2 infant deaths per 1,000 live births in 2018 to 6.9 infant deaths per 1,000 live births in 2019. The racial disparity for infant mortality remains a concern in SC, and the gap is now at its widest point in 5 years (see Figure 1 below). The infant mortality rate among births to minority women remained moderately constant from 2018 to 2019 (11.1 and 11.2, respectively) while the infant mortality rate among births to white mothers decreased 9.8% from 5.1 in 2018 to 4.6 infant deaths per 1,000 live births in 2019. -
Fermentation of Non-Digestible Oligosaccharides by Human Colonic Bacteria
Proceedings of the Nutrition Society ( 1996), 55,899-9 12 899 Symposium 2 Fermentation of non-digestible oligosaccharides by human colonic bacteria BY GLENN R. GIBSON, ANNE WILLEMS, SALLY READING AND M. DAVID COLLINS Department of Microbiology, Institute of Food Research, Earley Gate, Reading RG6 6BZ The principal substrates for colonic bacterial growth are dietary carbohydrates which have escaped digestion in the upper gastrointestinal tract. These may be starches, dietary fibres, other non-absorbable sugars, sugar alcohols and oligosaccharides. In the large intestine, saccharolytic bacteria are able to metabolize carbohydrates for increased energy and growth with short-chain fatty acids (SCFA) and a variety of other metabolites, such as the electron-sink products lactate, pyruvate, ethanol, H, and succinate, being produced. The majority of human large intestinal micro-organisms, have a strictly anaerobic metabolism, whilst numbers of facultative anaerobes are many orders of magnitude lower than those of the obligate anaerobes. Of the culturable flora, numerically predominant anaerobes are Gram-negative rods belonging to the genus Bacteroides. Other groups which have hitherto been identified as quantitatively significant include bifidobacteria, clostridia, eubacteria, lactobacilli, Gram-positive cocci, coliforms, methanogens and dissimilatory sulphate- reducing bacteria. Generally, the various components of the large intestinal microbiota may be considered as exerting either pathogenic effects or they may have potential health- promoting values. Bifidobacteria and lactobacilli are considered to belong to the latter group. Bacteria in the colon respond largely to the available fermentable substrate, and there is currently some interest in the use of diet to specifically increase groups perceived as health promoting. Non-digestible oligosaccharides seem to have this (prebiotic) potential. -
Degradation of Lipids in Yeast (Saccharomyces Cerevisiae) at the Early Phase of Organic Solvent-Induced Autolysis
Agric. Biol. Chem., 42 (2), 247•`251, 1978 Degradation of Lipids in Yeast (Saccharomyces cerevisiae) at the Early Phase of Organic Solvent-induced Autolysis MichikoISHIDA-ICHIMASA Departmentof Biology, Faculty of Science,Ibaraki University , Bunkyo,Mito, Japan ReceivedMay 30, 1977 Initial stage of organic solvent-induced autolysis in yeast was studied with 14C-acetate labeled cells. In the case of toluene-induced autolysis, primary cell injury which was estimated by leakage of UV absorbing substances from cell accompanied rapid deacylation of phos pholipids. Lysophospholipids did not occur during autolysis. When autolysis was induced by addition of ethyl acetate, phospholipids of yeast cells were not degraded so much. Ethyl acetate rather inhibited yeast phospholipase activity under the condition tested. Several organic solvents have been used to Extraction and analysis of lipids. The incubated mixtures were heated for 10 min in boiling water and initiate autolysis in yeast for the isolation of sonicated twice for 5 min at 20 KC in an ice bath. enzymes and other cell constituents. Some Then, lipids were extracted from the aqueous suspen examples are the applications of chloroform or sion by the procedure described by Bligh and Dyer.7) ethanol, toluene and ethyl acetate in the prepa Appropriate amounts of extracted lipids were chro rations of proteases,l) ƒÀ-fructofuranosidase,2,3) matographed on precoated thin-layer plates of silica gel 60 (without fluorescent indicator) (E. Merck Co.) with and cytochrome c,4) respectively. Although it solvents of petroleum ether-diethyl ether-acetic acid is well known that some organic solvents such (80: 30: 1, by vol8)) for neutral lipids, and chloroform- as diethyl ether and ethanol stimulate enzy methanol-acetic acid-water (25: 15: 4: 1, by vol.) for matic degradation of phospholipids, the me phospholipids.